Avanir Pharmaceuticals To Present At Two Investor Conferences In August

ALISO VIEJO, Calif., Aug. 7, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following investor conferences in August.

• Canaccord Genuity Annual Growth Conference
  • Location: Intercontinental Hotel, Boston, MA
  • Presentation date: Tuesday August 14, 2012
  • Presentation time: 9:30 a.m. ET
    
• Wedbush Life Sciences Conference
  • Location: Le Parker Meridien, New York, NY
  • Presentation date: Wednesday August 15, 2012
  • Presentation time: 1:20 p.m. ET

A live webcast and 30-day archive of these presentations will be available at http://www.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

^©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.

RELATED LINKS
http://www.avanir.com